rs114759137

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365999.1(SZT2):ā€‹c.5535T>Gā€‹(p.Ser1845Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,613,606 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.014 ( 53 hom., cov: 32)
Exomes š‘“: 0.0014 ( 42 hom. )

Consequence

SZT2
NM_001365999.1 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.43
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SZT2. . Gene score misZ 2.5968 (greater than the threshold 3.09). Trascript score misZ 4.0086 (greater than threshold 3.09). GenCC has associacion of gene with undetermined early-onset epileptic encephalopathy, developmental and epileptic encephalopathy, 18, developmental and epileptic encephalopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0017289519).
BP6
Variant 1-43432732-T-G is Benign according to our data. Variant chr1-43432732-T-G is described in ClinVar as [Benign]. Clinvar id is 260618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-43432732-T-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0141 (2149/151894) while in subpopulation AFR AF= 0.0493 (2041/41370). AF 95% confidence interval is 0.0476. There are 53 homozygotes in gnomad4. There are 997 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 53 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SZT2NM_001365999.1 linkuse as main transcriptc.5535T>G p.Ser1845Arg missense_variant 39/72 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkuse as main transcriptc.5364T>G p.Ser1788Arg missense_variant 38/71 NP_056099.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkuse as main transcriptc.5535T>G p.Ser1845Arg missense_variant 39/725 NM_001365999.1 ENSP00000489255 P1Q5T011-1

Frequencies

GnomAD3 genomes
AF:
0.0141
AC:
2138
AN:
151776
Hom.:
51
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0492
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00499
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000833
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.00360
AC:
902
AN:
250470
Hom.:
13
AF XY:
0.00263
AC XY:
356
AN XY:
135424
show subpopulations
Gnomad AFR exome
AF:
0.0498
Gnomad AMR exome
AF:
0.00209
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000618
Gnomad OTH exome
AF:
0.00213
GnomAD4 exome
AF:
0.00142
AC:
2078
AN:
1461712
Hom.:
42
Cov.:
33
AF XY:
0.00126
AC XY:
918
AN XY:
727148
show subpopulations
Gnomad4 AFR exome
AF:
0.0499
Gnomad4 AMR exome
AF:
0.00277
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000174
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000477
Gnomad4 OTH exome
AF:
0.00323
GnomAD4 genome
AF:
0.0141
AC:
2149
AN:
151894
Hom.:
53
Cov.:
32
AF XY:
0.0134
AC XY:
997
AN XY:
74190
show subpopulations
Gnomad4 AFR
AF:
0.0493
Gnomad4 AMR
AF:
0.00491
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000625
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.0114
Alfa
AF:
0.00238
Hom.:
10
Bravo
AF:
0.0164
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0508
AC:
224
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00435
AC:
528
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 05, 2018- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 08, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Developmental and epileptic encephalopathy, 18 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 18, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
12
DANN
Uncertain
0.98
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.55
T;T
MetaRNN
Benign
0.0017
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-2.5
.;N
Sift
Uncertain
0.019
.;D
Sift4G
Uncertain
0.020
D;D
Polyphen
0.0010
.;B
Vest4
0.14
MutPred
0.15
.;Loss of phosphorylation at S1788 (P = 0.0151);
MVP
0.17
MPC
0.29
ClinPred
0.0023
T
GERP RS
-4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.063
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114759137; hg19: chr1-43898403; API